156 related articles for article (PubMed ID: 15752380)
1. Mechanistic pharmacokinetic modelling of ephedrine, norephedrine and caffeine in healthy subjects.
Csajka C; Haller CA; Benowitz NL; Verotta D
Br J Clin Pharmacol; 2005 Mar; 59(3):335-45. PubMed ID: 15752380
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use.
Haller CA; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2002 Jun; 71(6):421-32. PubMed ID: 12087345
[TBL] [Abstract][Full Text] [Related]
3. Enhanced stimulant and metabolic effects of combined ephedrine and caffeine.
Haller CA; Jacob P; Benowitz NL
Clin Pharmacol Ther; 2004 Apr; 75(4):259-73. PubMed ID: 15060505
[TBL] [Abstract][Full Text] [Related]
4. Sensitive determination of ephedrine and norephedrine in human plasma samples using derivatization with 9-fluorenylmethyl chloroformate and liquid chromatography.
Aymard G; Labarthe B; Warot D; Berlin I; Diquet B
J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(1):25-31. PubMed ID: 10985563
[TBL] [Abstract][Full Text] [Related]
5. Detection and elimination profile of cathinone in equine after norephedrine (Propalin®) administration using a validated liquid chromatography-tandem mass spectrometry method.
Yi R; Zhao S; Lam G; Sandhu J; Loganathan D; Morrissey B
Anal Bioanal Chem; 2013 Dec; 405(30):9711-22. PubMed ID: 23954941
[TBL] [Abstract][Full Text] [Related]
6. Modelling the cardiovascular effects of ephedrine.
Persky AM; Berry NS; Pollack GM; Brouwer KL
Br J Clin Pharmacol; 2004 May; 57(5):552-62. PubMed ID: 15089807
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of oral decongestants.
Kanfer I; Dowse R; Vuma V
Pharmacotherapy; 1993; 13(6 Pt 2):116S-128S; discussion 143S-146S. PubMed ID: 7507589
[TBL] [Abstract][Full Text] [Related]
8. Unaltered etanercept pharmacokinetics with concurrent methotrexate in patients with rheumatoid arthritis.
Zhou H; Mayer PR; Wajdula J; Fatenejad S
J Clin Pharmacol; 2004 Nov; 44(11):1235-43. PubMed ID: 15496641
[TBL] [Abstract][Full Text] [Related]
9. Direct determination of ephedrine and norephedrine in human urine by capillary zone electrophoresis.
Chicharro M; Zapardiel A; Bermejo E; Perez JA; Hernández L
J Chromatogr; 1993 Dec; 622(1):103-8. PubMed ID: 8120107
[TBL] [Abstract][Full Text] [Related]
10. Five cases of fatal overdose from caffeine-containing "look-alike" drugs.
Garriott JC; Simmons LM; Poklis A; Mackell MA
J Anal Toxicol; 1985; 9(3):141-3. PubMed ID: 4010239
[TBL] [Abstract][Full Text] [Related]
11. [Simultaneous determination of ephedrine and chlorpheniramine in human plasma by a highly sensitive liquid chromatography-tandem mass spectrometric method].
Ren S; Chen XY; Duan XT; Zhong DF
Yao Xue Xue Bao; 2006 Feb; 41(2):188-92. PubMed ID: 16671554
[TBL] [Abstract][Full Text] [Related]
12. A simultaneous oral/intravenous population pharmacokinetic model for vinorelbine.
Variol P; Nguyen L; Tranchand B; Puozzo C
Eur J Clin Pharmacol; 2002 Oct; 58(7):467-76. PubMed ID: 12389069
[TBL] [Abstract][Full Text] [Related]
13. [Caffeine-11C, ephedrine-11C and methylephedrine-11C: Synthesis and distribution in mice (author's transl)].
Saji H; Ido T; Iwata R; Suzuki K; Tamate K; Yoshikawa K; Kasida Y
Radioisotopes; 1978 Aug; 27(8):451-5. PubMed ID: 734163
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics of caffeine and its metabolites theobromine, paraxanthine and theophylline after inhalation in combination with diacetylmorphine.
Zandvliet AS; Huitema AD; de Jonge ME; den Hoed R; Sparidans RW; Hendriks VM; van den Brink W; van Ree JM; Beijnen JH
Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):71-9. PubMed ID: 15667599
[TBL] [Abstract][Full Text] [Related]
15. Determination of ephedrine and related compounds in pharmaceutical preparations by ion chromatography with direct conductivity detection.
Ouyang J; Gao X; Baeyens WR; Delanghe JR
Biomed Chromatogr; 2005 May; 19(4):266-71. PubMed ID: 15651083
[TBL] [Abstract][Full Text] [Related]
16. [Accumulation of ephedrine, norephedrine, amphetamine and tyramine labeled with carbon 14 in pigmented and non-pigmented eyes in two races of rats].
Wepierre J; Cohen Y; Rapin J
Arch Int Pharmacodyn Ther; 1975 Oct; 217(2):342-50. PubMed ID: 1190927
[TBL] [Abstract][Full Text] [Related]
17. Elimination of ephedrines in urine following administration of a Sho-seiryu-to preparation.
Chan KH; Hsu MC; Chen FA; Hsu KF
J Anal Toxicol; 2009 Apr; 33(3):162-6. PubMed ID: 19371465
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of propafenone on the pharmacokinetics of caffeine in humans.
Michaud V; Mouksassi MS; Labbé L; Bélanger PM; Ferron LA; Gilbert M; Grech-Bélanger O; Turgeon J
Ther Drug Monit; 2006 Dec; 28(6):779-83. PubMed ID: 17164694
[TBL] [Abstract][Full Text] [Related]
19. [Effect on pharmacokinetics of pseudo-ephedrine in human plasma among herbs in Mahuang decoction].
He F; Luo JB
Zhongguo Zhong Yao Za Zhi; 2005 Sep; 30(18):1454-7. PubMed ID: 16381471
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic comparisons of five ephedrine alkaloids following oral administration of four different Mahuang-Guizhi herb-pair aqueous extracts ratios in rats.
Wei P; Huo HL; Ma QH; Li HC; Xing XF; Tan XM; Luo JB
J Ethnopharmacol; 2014 Aug; 155(1):642-8. PubMed ID: 24929107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
